1. Home
  2. VLN vs BIOA Comparison

VLN vs BIOA Comparison

Compare VLN & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLN
  • BIOA
  • Stock Information
  • Founded
  • VLN 2006
  • BIOA 2015
  • Country
  • VLN Israel
  • BIOA United States
  • Employees
  • VLN N/A
  • BIOA N/A
  • Industry
  • VLN Semiconductors
  • BIOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLN Technology
  • BIOA Health Care
  • Exchange
  • VLN Nasdaq
  • BIOA Nasdaq
  • Market Cap
  • VLN 188.2M
  • BIOA 175.7M
  • IPO Year
  • VLN N/A
  • BIOA 2024
  • Fundamental
  • Price
  • VLN $1.55
  • BIOA $9.26
  • Analyst Decision
  • VLN Strong Buy
  • BIOA Hold
  • Analyst Count
  • VLN 1
  • BIOA 4
  • Target Price
  • VLN $3.00
  • BIOA $9.00
  • AVG Volume (30 Days)
  • VLN 896.4K
  • BIOA 276.7K
  • Earning Date
  • VLN 11-12-2025
  • BIOA 11-06-2025
  • Dividend Yield
  • VLN N/A
  • BIOA N/A
  • EPS Growth
  • VLN N/A
  • BIOA N/A
  • EPS
  • VLN N/A
  • BIOA N/A
  • Revenue
  • VLN $67,887,000.00
  • BIOA $5,917,000.00
  • Revenue This Year
  • VLN $18.39
  • BIOA N/A
  • Revenue Next Year
  • VLN $16.93
  • BIOA N/A
  • P/E Ratio
  • VLN N/A
  • BIOA N/A
  • Revenue Growth
  • VLN 7.53
  • BIOA N/A
  • 52 Week Low
  • VLN $1.37
  • BIOA $2.88
  • 52 Week High
  • VLN $3.50
  • BIOA $20.37
  • Technical
  • Relative Strength Index (RSI)
  • VLN 44.74
  • BIOA 75.44
  • Support Level
  • VLN $1.37
  • BIOA $7.60
  • Resistance Level
  • VLN $1.59
  • BIOA $9.33
  • Average True Range (ATR)
  • VLN 0.12
  • BIOA 0.43
  • MACD
  • VLN -0.00
  • BIOA 0.07
  • Stochastic Oscillator
  • VLN 38.00
  • BIOA 98.84

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: